Global Bromhexine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bromhexine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Bromhexine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bromhexine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Bronchitis and Asthma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bromhexine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Bromhexine key manufacturers include Sanofi Aventis, Teva, Boehringer Ingelheim, Novartis, Mylan, Sanyo Chemical Laboratroy, Sandoz, LGM Pharma and GSK, etc. Sanofi Aventis, Teva, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
Bromhexine can be divided into Oral and Injection, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Bromhexine is widely used in various fields, such as Chronic Bronchitis, Asthma and Others,, etc. Chronic Bronchitis provides greatest supports to the Bromhexine industry development. In 2022, global % sales of Bromhexine went into Chronic Bronchitis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bromhexine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi Aventis
Teva
Boehringer Ingelheim
Novartis
Mylan
Sanyo Chemical Laboratroy
Sandoz
LGM Pharma
GSK
Mayne Pharma
Sigma-Aldrich
Abbott
Shanghai Sine Tianping Pharmaceutical
Takeda
Shanghai Xudong Haipu Pharmaceutical
Jincheng Haisi Pharmaceutical
Shanxi Powerdone Pharmaceutical
Shanxi Powerdone Pharmaceutical
Wanbangde Pharmaceutical Group
Shijiazhuang No.4 Pharmaceutical
Ma'AnShan BBCA Pharmaceutical
Segment by Type
Oral
Injection
Chronic Bronchitis
Asthma
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bromhexine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bromhexine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bromhexine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bromhexine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bromhexine introduction, etc. Bromhexine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Bromhexine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Bromhexine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Bromhexine key manufacturers include Sanofi Aventis, Teva, Boehringer Ingelheim, Novartis, Mylan, Sanyo Chemical Laboratroy, Sandoz, LGM Pharma and GSK, etc. Sanofi Aventis, Teva, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
Bromhexine can be divided into Oral and Injection, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Bromhexine is widely used in various fields, such as Chronic Bronchitis, Asthma and Others,, etc. Chronic Bronchitis provides greatest supports to the Bromhexine industry development. In 2022, global % sales of Bromhexine went into Chronic Bronchitis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bromhexine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi Aventis
Teva
Boehringer Ingelheim
Novartis
Mylan
Sanyo Chemical Laboratroy
Sandoz
LGM Pharma
GSK
Mayne Pharma
Sigma-Aldrich
Abbott
Shanghai Sine Tianping Pharmaceutical
Takeda
Shanghai Xudong Haipu Pharmaceutical
Jincheng Haisi Pharmaceutical
Shanxi Powerdone Pharmaceutical
Shanxi Powerdone Pharmaceutical
Wanbangde Pharmaceutical Group
Shijiazhuang No.4 Pharmaceutical
Ma'AnShan BBCA Pharmaceutical
Segment by Type
Oral
Injection
Segment by Application
Chronic Bronchitis
Asthma
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bromhexine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bromhexine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bromhexine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bromhexine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bromhexine introduction, etc. Bromhexine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Bromhexine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.